Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00483158
Status:
COMPLETED
Last Update Posted:
2008-07-29
First Post:
2007-06-04
Brief Title:
First Time in Man Study of Finafloxacin Hydrochloride
Sponsor:
MerLion Pharmaceuticals GmbH
Organization:
MerLion Pharmaceuticals GmbH
Organization Data
Organization:
MerLion Pharmaceuticals GmbH
Class:
INDUSTRY
Study ID:
FINA-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MerLion Pharmaceuticals GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Michael Seiberling MD Prinzipal Study Investigator
Old Organization:
Swiss Pharma Contract Basel Switzerland